Community post

Daniel Lauster (Freie Universität Berlin) and colleagues published a Nature Nanotechnology paper showing their use of phage capsid nanoparticles to block influenza virus entry into cells, leading to inhibition of infection in vitro and in vivo. Perhaps a worthwhile strategy to target COVID-19?